Earnings Feed
Start Free
Home/Filings/4/A/0001209191-13-017279
4/A//SEC Filing

WATSON DOUGLAS G 4/A

Accession 0001209191-13-017279

CIK 0001138400other
View on SEC.govCompany Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 5:45 PM ET

Size

13.6 KB

Accession

0001209191-13-017279

Insider Transaction Report

Form 4/AAmended
Period: 2013-03-01
BIOMIMETIC THERAPEUTICS, INC.BMTI
WATSON DOUGLAS G
Director
Transactions
  • Disposition to Issuer

    Stock Options (right to buy)

    2013-03-01−8,840→ 0 total
    Exercise: $11.64Exp: 2018-06-19→ Commmon Stock (8,840 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2013-03-01−8,538→ 0 total
    Exercise: $12.66Exp: 2020-06-17→ Commmon Stock (8,538 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2013-03-01−10,653→ 0 total
    Exercise: $9.95Exp: 2019-06-19→ Commmon Stock (10,653 underlying)
Footnotes (3)
  • [F1]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,611 shares of Wright common stock at an exercise price of $22.32 per share.
  • [F2]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,557 shares of Wright common stock at an exercise price of $19.08 per share.
  • [F3]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,454 shares of Wright common stock at an exercise price of $24.27 per share.

Documents

2 files

Issuer

BIOMIMETIC THERAPEUTICS, INC.

CIK 0001138400

→
Entity typeother

Related Parties

1
  • filerCIK 0001171147

Filing Metadata

Form type
4/A
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:45 PM ET
Size
13.6 KB
View on SEC.gov